Trial Profile
Clinical, Endoscopic and Radiographic Efficacy of Vedolizumab in patients with Inflammatory Bowel Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Aug 2018
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Inflammatory bowel diseases
- Focus Therapeutic Use
- 03 Aug 2018 New trial record
- 31 Jul 2018 Results published in the Alimentary Pharmacology and Therapeutics